Atlas Trials

A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease

Clinical trial NCT01843790 · COMPLETED

Trial details

NCT number
NCT01843790
Sponsor
La Jolla Pharmaceutical Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2013-06-01
Primary completion
2014-02-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.